Picture of a sphere with binary code

Making Strathclyde research discoverable to the world...

The Strathprints institutional repository is a digital archive of University of Strathclyde research outputs. It exposes Strathclyde's world leading Open Access research to many of the world's leading resource discovery tools, and from there onto the screens of researchers around the world.

Explore Strathclyde Open Access research content

Cryopreservation of hepatocytes: the monolayer approach

Stevenson, D.J. and Grant, M.H. and Goldie, E.I. and Connel, G. and Morgan, C. (2002) Cryopreservation of hepatocytes: the monolayer approach. In: RSC-DMG 2002: New Technologies in Drug Discovery, 2002-12-12 - 2002-12-13.

Full text not available in this repository. (Request a copy from the Strathclyde author)

Abstract

The ability to cryopreserve hepatocytes would be useful both to the pharmaceutical industry and for bioartificial liver support systems. Unfortunately, suspension cryopreservation protocols typically result in low attachment efficiencies of cells upon thawing. To circumvent this problem, we have frozen rat hepatocytes as monolayers on collagen substrates, and attempted to optimise this cryopreservation protocol. A variety of parameters were measured in non-frozen and post-thaw frozen monolayer cultures, including viability, total protein and intracellular reduced glutathione (GSH) concentration, kaempherol glucuronidation, and testosterone hydroxylation. The effect of altering cryopreservation media composition (% of foetal calf serum varying between 0-90%) or freezing (0.4-3.8ºC/min) and thawing rates (26-128ºC/min) on these parameters was investigated. Under optimal conditions, post thaw cryopreserved cells maintained 72±4% viability, 65±4% total protein, 46±8% GSH, 48±8% kaempherol glucuronidation, and 16±11% testosterone hydroxylation of their corresponding non-frozen controls (mean ±SEM, n=3). Cryopreservation of hepatocyte monolayers as opposed to suspensions results in a more representative population of cells, with high viability, function, and recovery rates.